NSW Minister for Medical Research, Pru Goward has announced a $12 million investment in Australia's first large-scale automated biobank, due to open in 2017.
To avoid the occurrence of and to treat already existing pressure sores, researchers at Fraunhofer IIS, Germany, in collaboration with five partners in the INSYDE research project, have succeeded in developing the technological prototype of an intelligent and adaptive mattress.
A reduction in the therapeutic radiation dose used to treat paediatric cancers is likely the cause of a drop in subsequent cancer in children, according to a study appearing in the 28 February issue of JAMA.
Australian researchers have discovered remarkable evolutionary changes to insulin regulation in the platypus and the echidna — which could pave the way for new treatments for type 2 diabetes in humans.
Three Australians are diagnosed with oral cancer every day.
A test that measures the levels of five chemicals in the breath has shown promising results for the detection of cancers of the oesophagus and stomach in a large patient trial presented at the European Cancer Congress 2017.
In a second human case, a Yale-led research team has found that a melanoma cell and a white blood cell can fuse to form a hybrid with the ability to metastasize. The finding provides further insight into how melanoma and other cancers spread from solid tumours with implications for future treatment.
The National Eye Health Survey Report has been released by the federal government. It involved completing a series of eye tests on around 5000 Australian across 30 geographical areas.
Platelets can be used to deliver anticancer treatment to the site of a surgically removed tumour, reports a paper published in Nature Biomedical Engineering.
An in-depth genomic and molecular analysis of cervical cancer, reported in Nature this week, reveals potential new therapeutic targets for the disease, which remains one of the leading causes of cancer-related deaths globally.
Using large patient databases for healthcare decision-making in cancer could improve quality of life and decrease healthcare costs, according to a paper published online this week in Nature Genetics.
A landmark study has revealed the reason why men with a family history of prostate cancer who also carry the BRCA2 gene fault have a more aggressive form of prostate cancer.
"Our study has shown that Colvera is significantly more sensitive for bowel cancer than CEA and as such provides us with an improved, simple test that increases the likelihood of detecting curable recurrence," Professor Young said.
Reduced scarring and the ability to treat multiple lesions at once are two perks of Australia's first low energy X-ray treatment for skin cancer.
Between 2005 and 2015, the number of cancer cases worldwide increased by 33%, with an estimated 17.5 million cancer cases and 8.7 million deaths, according to a global research collaboration involving Australian institutions.